William F. Hahne
Nessuna posizione attualmente
Storia della carriera di William F. Hahne
Precedenti posizioni note di William F. Hahne
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IMUNON, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2006 | 01/12/2007 |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Direttore Tecnico/Scientifico/R&S | 01/01/2003 | 01/01/2005 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Direttore Tecnico/Scientifico/R&S | 01/01/1997 | 01/01/2002 |
| BIO-PATH HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 17/04/2017 | - |
| Corporate Officer/Principal | - | - | |
Vion Pharmaceuticals, Inc.
 Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Direttore Tecnico/Scientifico/R&S | 01/02/2008 | - |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di William F. Hahne
| Cornell University | Doctorate Degree |
| Grinnell College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Chief Tech/Sci/R&D Officer | 6 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| IMUNON, INC. | Health Technology |
| BIO-PATH HOLDINGS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Vion Pharmaceuticals, Inc.
Vion Pharmaceuticals, Inc. BiotechnologyHealth Technology Vion Pharmaceuticals, Inc. develops therapeutics for the treatment of cancer. The company was founded in March 1992 and is headquartered in New Haven, CT. | Health Technology |
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
- Borsa valori
- Insiders
- William F. Hahne
- Esperienza
